The European Partnership for Personalised Medicine, EP PerMed (supported by the European Union under Horizon Europe, Grant Agreement N° 101137129), is a platform for joint programming of national and European regional research and innovation supporting activities putting into action The Strategic Research & Innovation Agenda (SRIA) for Personalised Medicine (2023), SRIA for PM (2023), through dedicated research, development and innovation funding.
EP PerMed funding organisations, listed below, have agreed to launch the joint transnational call 2024 (JTC2024), co-funded by the EU, to fund multinational innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe in this field. The JTC2024 will be conducted simultaneously by the participating funding organisations in their respective region/country and coordinated centrally by the Joint Call Secretariat (JCS), hosted by the French National Research Agency, (ANR), France.
The call will be implemented in two stages, i.e. a pre- and a full-proposal phase. The call calendar, including the deadline for pre- and full-proposal submission, will be available soon. The call is expected to be launched beginning of January 2024.
The available budget for this call is 40 Mio. € (approx.).